alpha-aminopyridine has been researched along with Cytomegalovirus Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bäuerle, T; Bertzbach, LD; Conradie, AM; Eickhoff, J; Hahn, F; Kaufer, BB; Kicuntod, J; Marschall, M; Michel, D; Seyler, L; Tsogoeva, SB; Wagner, S; Wangen, C; Wild, M | 1 |
Buchner, M; Fisch, P; Gerlach, UV; Hechinger, AK; Leonhardt, F; Prinz, G; Reichardt, W; Schmitt-Gräff, A; Zeiser, R; Zirlik, K | 1 |
2 other study(ies) available for alpha-aminopyridine and Cytomegalovirus Infections
Article | Year |
---|---|
Combinatorial Drug Treatments Reveal Promising Anticytomegaloviral Profiles for Clinically Relevant Pharmaceutical Kinase Inhibitors (PKIs).
Topics: Aminopyridines; Animals; Antiviral Agents; Benzimidazoles; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Drug Combinations; Drug Resistance, Viral; Ganciclovir; Humans; Mice; Protein Kinase Inhibitors; Pyrazoles; Ribonucleosides; Triazines; Virus Replication | 2021 |
Spleen tyrosine kinase (Syk) is a potent target for GvHD prevention at different cellular levels.
Topics: Aminopyridines; Animals; Antigen-Presenting Cells; Blotting, Western; Bone Marrow Transplantation; Cell Movement; Cell Proliferation; Cytomegalovirus; Cytomegalovirus Infections; Dendritic Cells; Female; Flow Cytometry; Graft vs Host Disease; Graft vs Leukemia Effect; Intracellular Signaling Peptides and Proteins; Leukemia; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Morpholines; Oxazines; Phosphorylation; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Spleen; Syk Kinase; T-Lymphocytes; Transplantation, Homologous | 2012 |